• Neuroinformatics
• Open Access close
• 3. Good health close

As the number of women who use alcohol increases, so does the number of women who engage in alcohol abuse and develop alcohol dependence. The recent increased focus on women and gender differences in alcoholism research has largely come about following recognition that the face of alcoholism is changing, with alcoholism rates among men remaining stable and rising among women, particularly in younger women. As such, the need to understand gender differences in both acute and long-term effects of alcohol abuse has never been more critical. Gender differences in the long-term effects of chronic alcoholism on the brain and other systems are currently under debate, often with a focus on proclaiming whether men or women suffer the most impact. However, the story appears to be more complex than that. The issue of how alcoholism interacts with gender is complicated, as gender differences in many factors including alcohol metabolism, alcoholism progression, problematic drinking patterns, neurobiology, hormones, and psychiatric comorbidities will contribute to the differences in structural and functional outcomes observed experimentally across domains of inquiry. While women are now much more commonly included in studies of alcohol’s effects on the brain, there remains a need for more explicit examinations of gender effects.

The first kinase inhibitor drug approval in 2001 initiated a remarkable decade of tyrosine kinase inhibitor drugs for oncology indications, but a void exists for serine/threonine protein kinase inhibitor drugs and central nervous system indications. Stress kinases are of special interest in neurological and neuropsychiatric disorders due to their involvement in synaptic dysfunction and complex disease susceptibility. Clinical and preclinical evidence implicates the stress related kinase p38αMAPK as a potential neurotherapeutic target, but isoform selective p38αMAPK inhibitor candidates are lacking and the mixed kinase inhibitor drugs that are promising in peripheral tissue disease indications have limitations for neurologic indications. Therefore, pursuit of the neurotherapeutic hypothesis requires kinase isoform selective inhibitors with appropriate neuropharmacology features. Synaptic dysfunction disorders offer a potential for enhanced pharmacological efficacy due to stress-induced activation of p38αMAPK in both neurons and glia, the interacting cellular components of the synaptic pathophysiological axis, to be modulated. We report a novel isoform selective p38αMAPK inhibitor, MW01-18-150SRM (=MW150), that is efficacious in suppression of hippocampal-dependent associative and spatial memory deficits in two distinct synaptic dysfunction mouse models. A synthetic scheme for biocompatible product and positive outcomes from pharmacological screens are presented. The high-resolution crystallographic structure of the p38αMAPK/MW150 complex documents active site binding, reveals a potential low energy conformation of the bound inhibitor, and suggests a structural explanation for MW150's exquisite target selectivity. As far as we are aware, MW150 is without precedent as an isoform selective p38MAPK inhibitor or as a kinase inhibitor capable of modulating in vivo stress related behavior.

AbstractWater-in-oil emulsions having their aqueous internal phase gelled with starch were prepared and investigated. They were the primary emulsions required for the preparation of double w/o/w emulsions that could encapsulate hydrophilic materials inside the internal aqueous gel. The emulsification could be achieved at high temperature in spite of the high viscosity of the aqueous phase; the internal phase gelled upon cooling to room temperature. The high viscosity of the aqueous phase limited the possible concentration range of starch in the aqueous phase. The presence of starch made the surfactant demand larger for both the emulsification and the stabilization of the w/o emulsions. The larger the starch content, the larger the amount of required surfactant. One reason for the high surfactant demand was the high viscosity of the aqueous phase containing starch. Another cause of high surfactant demand was disclosed and it appeared that predominantly the interactions of the nonionic surfactants with starch retained the former inside the aqueous phase. The immobilized amount of surfactant had to be compensated by a supplementary concentration. Experimental evidence of the interactions between starch and the nonionic surfactants was given by interfacial tension measurements. Lastly, w/o/w double emulsions were prepared using the gelled w/o emulsions and a model hydrophilic molecule (caffeine) was encapsulated inside the internal gelled aqueous phase. The release rate of caffeine from the internally gelled double emulsions was slower than for the non-gelled emulsions, demonstrating the efficiency of the encapsulation and the possible control of the delivery.

A dysfunctional endosomal pathway and abnormally enlarged early endosomes in neurons are an early characteristic of Down syndrome (DS) and Alzheimer’s disease (AD). We have hypothesized that endosomal material can be released by endosomal multivesicular bodies (MVBs) into the extracellular space via exosomes to relieve neurons of accumulated endosomal contents when endosomal pathway function is compromised. Supporting this, we found that exosome secretion is enhanced in the brains of DS patients and a mouse model of the disease, and by DS fibroblasts. Furthermore, increased levels of the tetraspanin CD63, a regulator of exosome biogenesis, were observed in DS brains. Importantly, CD63 knockdown diminished exosome release and worsened endosomal pathology in DS fibroblasts. Taken together, these data suggest that increased CD63 expression enhances exosome release as an endogenous mechanism mitigating endosomal abnormalities in DS. Thus, the upregulation of exosome release represents a potential therapeutic goal for neurodegenerative disorders with endosomal pathology. Electronic supplementary material The online version of this article (doi:10.1186/s40478-017-0466-0) contains supplementary material, which is available to authorized users.

Carbon monoxide (CO) at low concentrations imparts protective effects in numerous preclinical small animal models of brain injury. Evidence of protection in large animal models of cerebral injury, however, has not been tested. Neurologic deficits following open heart surgery are likely related in part to ischemia reperfusion injury that occurs during cardiopulmonary bypass surgery. Using a model of deep hypothermic circulatory arrest (DHCA) in piglets, we evaluated the effects of CO to reduce cerebral injury. DHCA and cardiopulmonary bypass (CPB) induced significant alterations in metabolic demands, including a decrease in the oxygen/glucose index (OGI), an increase in lactate/glucose index (LGI) and a rise in cerebral blood pressure that ultimately resulted in increased cell death in the neocortex and hippocampus that was completely abrogated in piglets preconditioned with a low, safe dose of CO. Moreover CO-treated animals maintained normal, pre-CPB OGI and LGI and corresponding cerebral sinus pressures with no change in systemic hemodynamics or metabolic intermediates. Collectively, our data demonstrate that inhaled CO may be beneficial in preventing cerebral injury resulting from DHCA and offer important therapeutic options in newborns undergoing DHCA for open heart surgery.

The hippocampus is located within the medial temporal lobe and plays a key role in learning and episodic, semantic, and spatial memory. Dysfunction has been reported in neurologic and psychiatric disorders including epilepsy (Wu et al., 2005), Alzheimer's disease (Apostolova et al., 2006), schizophrenia (Tanskanen et al., 2005), and depression (Bremner et al., 2000). Temporal lobe epilepsy (TLE) is the most common drug-resistant focal epilepsy, with seizures frequently arising from the hippocampus. In surgical series of TLE, the pathology is often hippocampal sclerosis (HS) comprising neuronal loss and gliosis and marked by atrophy and signal change on magnetic resonance imaging (Van Paesschen, 2004). Atrophy of the hippocampus through HS provides a good biomarker for the laterality of the seizure focus (Bernasconi et al., 2003), and combined with concordant neurophysiology and neuropsychological data can be sufficient to recommend surgery. Hippocampal atrophy is associated with a favorable surgical outcome (Schramm & Clusmann, 2008). Visual assessment of hippocampal volumes is unreliable, as it may be compromised by head position and primarily detects hippocampal asymmetry rather than volume loss, making bilateral atrophy difficult to identify. Hippocampal segmentation and volumetry are thus important for diagnosis and surgical planning (Watson et al., 1997). The gold standard for hippocampal segmentation is manual delineation by trained raters. This is accurate, reproducible, and sensitive but is time-consuming, requires anatomic knowledge, and is subject to interrater and intrarater variability. The hippocampus is challenging to delineate as it is small and highly variable with ill-defined margins. Many protocols exist for manual segmentation depending on which structures are included and the boundary definition (Konrad et al., 2009). Automated segmentation techniques aim to ensure operator independence, high reproducibility, and reduced demand for human time and expertise. The strongest drive for automation has come from researchers working with large cohorts of patients with Alzheimer's disease patients. Hippocampal volumes are an early marker for the disease, are related to cognitive status, and may reflect disease progression in clinical trials (Frisoni & Jack, 2011). In atlas-based segmentation approaches, a template and associated manual labels are registered (matched) to the new image (Carmichael et al., 2005). Commonly used methods, including FreeSurfer (Fischl et al., 2002), rely on a single template so that subjects that differ significantly from the template, for example HS, are poorly segmented. Segmentation of hippocampi that are sclerotic is more challenging than segmenting hippocampi in Alzheimer's disease, as the latter is associated with more prominent cerebrospinal fluid (CSF)–hippocampal boundaries, whereas the former is associated with signal change. The use of an atlas with multiple template images is more effective than a single template (Heckemann et al., 2006) and depends on the quality of registration and template selection strategy. Most previous atlas-based segmentation studies used small template databases of healthy subjects. Results obtained in TLE are significantly worse than in healthy subjects or Alzheimer's disease (Kim et al., 2012), as aside from atrophy, approximately 40% of patients with TLE demonstrate an atypical shape or position of the hippocampus (Bernasconi et al., 2005). In this study, we adapted our published method developed for use in Alzheimer's disease (Cardoso et al., 2013) to a large cohort of adult patients with epilepsy by employing accurate nonlinear registration (Modat et al., 2010) and a large template database that encompasses the range of pathology observed in epilepsy at a tertiary referral center. Manual segmentations of the most similar images from the template database are combined using a label fusion strategy based on local similarity to ensure accurate segmentation regardless of pathology. We demonstrate that this technique achieves reliable segmentation with no more variability than that seen between different expert raters. The algorithm is made freely available via an online Web-based service (https://hipposeg.cs.ucl.ac.uk). In addition, the software, scripts, and an anonymized version of the template database are available from this website.

International audience; Hendra virus (HeV) and Nipah virus (NiV) are closely related, recently emerged paramyxoviruses that form Henipavirus genus and are capable of causing considerable morbidity and mortality in a number of mammalian species, including humans. However, in contrast to many other species and despite expression of functional virus entry receptors, mice are resistant to henipavirus infection. We report here the susceptibility of mice deleted for the type I interferon receptor (IFNAR-KO) to both HeV and NiV. Intraperitoneally infected mice developed fatal encephalitis, with pathology and immunohistochemical features similar to what was found in humans. Viral RNA was found in the majority of analyzed organs, and sublethally infected animals developed virus-specific neutralizing antibodies. Altogether, these results reveal IFNAR-KO mice as a new small animal model to study HeV and NiV pathogenesis, prophylaxis, and treatment and suggest the critical role of type I interferon signaling in the control of henipavirus infection.

Rho, Rac, and Cdc42 monomeric GTPases are well known regulators of the actin cytoskeleton and phosphoinositide metabolism and have been implicated in hormone secretion in endocrine cells. Here, we examine their possible implication in Ca(2+)-dependent exocytosis of neurotransmitters. Using subcellular fractionation procedures, we found that RhoA, RhoB, Rac1, and Cdc42 are present in rat brain synaptosomes; however, only Rac1 was associated with highly purified synaptic vesicles. To determine the synaptic function of these GTPases, toxins that impair Rho-related proteins were microinjected into Aplysia neurons. We used lethal toxin from Clostridium sordellii, which inactivates Rac; toxin B from Clostridium difficile, which inactivates Rho, Rac, and Cdc42; and C3 exoenzyme from Clostridium botulinum and cytotoxic necrotizing factor 1 from Escherichia coli, which mainly affect Rho. Analysis of the toxin effects on evoked acetylcholine release revealed that a member of the Rho family, most likely Rac1, was implicated in the control of neurotransmitter release. Strikingly, blockage of acetylcholine release by lethal toxin and toxin B could be completely removed in1 s by high frequency stimulation of nerve terminals. Further characterization of the inhibitory action produced by lethal toxin suggests that Rac1 protein regulates a late step in Ca(2+)-dependent neuroexocytosis.

International audience; In mature B cells, class switch recombination (CSR) replaces the expressed constant Cμ gene with a downstream C(H) gene. How the four transcriptional enhancers of the IgH 3' regulatory region (3'RR) control CSR remains an open question. We have investigated IgG1 CSR in 3'RR-deficient mice. Here we show that the 3'RR enhancers target the S(γ1) acceptor region (and poorly the S(μ) donor region) by acting on epigenetic marks, germline transcription, paused RNA Pol II recruitment, R loop formation, AID targeting and double-strand break generation. In contrast, location and diversity of S(μ)-S(γ1) junctions are not affected by deletion of the 3'RR enhancers. Thus, the 3'RR controls the first steps of CSR by priming the S acceptor region but is not implicated in the choice of the end-joining pathway.